Investment Trusts

RTW Biotech Opportunities Ltd

RTW:LSE

RTW Biotech Opportunities Ltd

  • Price (USD)1.52
  • Today's Change-0.005 / -0.33%
  • Shares traded114.13k
  • 1 Year change25.62%
  • Beta0.6458
Data delayed at least 15 minutes, as of Oct 04 2024 16:35 BST.
More ▼
Total returns on $1000
1Y
Fund/benchmarkChange
PriceRTW Biotech Opportunities Ltd (Ordinary Share)+25.41%
NAVRTW Biotech Opportunities Ltd (Ordinary Share)+26.42%
Morningstar's BenchmarkRussell 2000 Biotech Growth [50.00%]; Nasdaq Biotechnology Index [50.00%]--

Key statistics

On Friday, RTW Biotech Opportunities Ltd (RTW:LSE) closed at 1.52, -12.14% below its 52-week high of 1.73, set on Jul 31, 2024.
52-week range
Today
1.05Nov 02 20231.73Jul 31 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding335.71m
Market cap511.96m USD
Total assets674.78m USD
Total expense ratio1.97%
High1.57
Low1.52
Previous close1.53
Average volume119.36k
YTD Change+8.38%
Beta0.6458
Diluted NAV (est)2.01
Diluted NAV (last pub)2.01
Premium/Discount-24.38%
Net Gearing0.00%
Data delayed at least 15 minutes, as of Oct 04 2024 16:35 BST.
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.